These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36359470)

  • 41. Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly.
    Pan F; Cui W; Gao L; Shi X; Yang H; Hu Y; Li M
    J Clin Lab Anal; 2022 Apr; 36(4):e24350. PubMed ID: 35293029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urine Metabolomics Analysis in Patients With Normoalbuminuric Diabetic Kidney Disease.
    Feng Q; Li Y; Yang Y; Feng J
    Front Physiol; 2020; 11():578799. PubMed ID: 33123032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low Serum Dehydroepiandrosterone Is Associated With Diabetic Kidney Disease in Men With Type 2 Diabetes Mellitus.
    Zhang X; Xiao J; Li X; Cui J; Wang K; He Q; Liu M
    Front Endocrinol (Lausanne); 2022; 13():915494. PubMed ID: 35784547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization of kidney dysfunction prediction in diabetic kidney disease using targeted metabolomics.
    Ibarra-González I; Cruz-Bautista I; Bello-Chavolla OY; Vela-Amieva M; Pallares-Méndez R; Ruiz de Santiago Y Nevarez D; Salas-Tapia MF; Rosas-Flota X; González-Acevedo M; Palacios-Peñaloza A; Morales-Esponda M; Aguilar-Salinas CA; Del Bosque-Plata L
    Acta Diabetol; 2018 Nov; 55(11):1151-1161. PubMed ID: 30173364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma proteomics of diabetic kidney disease among Asians with younger-onset type 2 diabetes.
    Gurung RL; Zheng H; Koh HWL; Yiamunaa M; Liu JJ; Liu S; Chan C; Ang K; Tan CSH; Sobota RM; Subramaniam T; Sum CF; Lim SC
    J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38626182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uric Acid is independently associated with diabetic kidney disease: a cross-sectional study in a Chinese population.
    Yan D; Tu Y; Jiang F; Wang J; Zhang R; Sun X; Wang T; Wang S; Bao Y; Hu C; Jia W
    PLoS One; 2015; 10(6):e0129797. PubMed ID: 26029914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of Supersonic Shear Wave Imaging-Derived Renal Parenchyma Stiffness Between Diabetes Mellitus Patients With and Without Diabetic Kidney Disease.
    Shi LQ; Sun JW; Miao HH; Zhou XL
    Ultrasound Med Biol; 2020 Jul; 46(7):1630-1640. PubMed ID: 32404297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urine Immunoglobin G Greater Than 2.45 mg/L Has a Correlation with the Onset and Progression of Diabetic Kidney Disease: A Retrospective Cohort Study.
    Meng C; Chen J; Sun X; Guan S; Zhu H; Qin Y; Wang J; Li Y; Yang J; Chang B
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease.
    Pereira PR; Carrageta DF; Oliveira PF; Rodrigues A; Alves MG; Monteiro MP
    Med Res Rev; 2022 Jul; 42(4):1518-1544. PubMed ID: 35274315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Artemether Alleviates Diabetic Kidney Disease by Modulating Amino Acid Metabolism.
    Rong G; Weng W; Huang J; Chen Y; Yu X; Yuan R; Gu X; Wu X; Cai Y; Han P; Shao M; Sun H; Ge N
    Biomed Res Int; 2022; 2022():7339611. PubMed ID: 35601149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metformin regulates inflammation and fibrosis in diabetic kidney disease through TNC/TLR4/NF-κB/miR-155-5p inflammatory loop.
    Zhou Y; Ma XY; Han JY; Yang M; Lv C; Shao Y; Wang YL; Kang JY; Wang QY
    World J Diabetes; 2021 Jan; 12(1):19-46. PubMed ID: 33520106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan.
    Wang Y; Peng W; Zhang X; Qiao H; Wang L; Xu Z; Wu C
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27638852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes.
    Wang Z; Tang J; Jin E; Ren C; Li S; Zhang L; Zhong Y; Cao Y; Wang J; Zhou W; Zhao M; Huang L; Qu J
    Front Endocrinol (Lausanne); 2022; 13():986303. PubMed ID: 36157454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Markers of and risk factors for the development and progression of diabetic kidney disease.
    Macisaac RJ; Ekinci EI; Jerums G
    Am J Kidney Dis; 2014 Feb; 63(2 Suppl 2):S39-62. PubMed ID: 24461729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relation of serum heart type fatty acid binding protein to left ventricular diastolic dysfunction in patients with type 2 diabetes and early diabetic kidney disease.
    Abdelaaty T; Morsy E; Rizk M; Shokry A; Abdelhameid A; Fathalla R
    J Diabetes Complications; 2022 Mar; 36(3):108122. PubMed ID: 35123867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum uric acid levels and diabetic kidney disease in patients with type 2 diabetes mellitus: A dose-response meta-analysis.
    Ji P; Zhu J; Feng J; Li H; Yu Q; Qin H; Wei L; Zhang J
    Prim Care Diabetes; 2022 Jun; 16(3):457-465. PubMed ID: 35305901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk Factors for the Development and Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Advanced Diabetic Retinopathy.
    Yun KJ; Kim HJ; Kim MK; Kwon HS; Baek KH; Roh YJ; Song KH
    Diabetes Metab J; 2016 Dec; 40(6):473-481. PubMed ID: 27766790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of potential biomarkers for diabetic cardiomyopathy using LC-MS-based metabolomics.
    Xiong RQ; Li YP; Lin LP; Yao JY
    Endocr Connect; 2024 Mar; 13(3):. PubMed ID: 38180052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative profiling of carboxylic compounds by gas chromatography-mass spectrometry for revealing biomarkers of diabetic kidney disease.
    Zhu R; Yuan Y; Qi R; Liang J; Shi Y; Weng H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Dec; 1231():123930. PubMed ID: 38029665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.